Additionally, while this study utilized tamoxifen combination therapies administered concomitantly, it remains unknown if these compounds may provide benefit if prescribed in series, or if pre-treatment with tamoxifen affects the reduction in tumor burden and HER2 expression. Here, ERBB2 is linked to neoplasm.